• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN LP BARRX UNKNOWN BARRX; ELECTROSURGICAL, CUTTING & COAGULATION & ACCES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN LP BARRX UNKNOWN BARRX; ELECTROSURGICAL, CUTTING & COAGULATION & ACCES Back to Search Results
Model Number UNKNOWN BARRX
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Chest Pain (1776); Dysphagia/ Odynophagia (1815); Fever (1858); Hemorrhage/Bleeding (1888); Stenosis (2263)
Event Date 12/06/2022
Event Type  Injury  
Manufacturer Narrative
Title: predictive factors of radiofrequency ablation failure in the treatment of dysplastic barrett¿s esophagus.Source: clinics and research in hepatology and gastroenterology 47 (2023) 102065 available online 6 december 2022.Simon weiss, anna pellat, felix corre, einas abou ali, arthur belle, benoit terris, mahaut leconte, anthony dohand, stanislas chaussade, romain coriat, maximilien barret.Https://doi.Org/10.1016/j.Clinre.2022.102065.D10: concomitant product: unk-barrx 360, unknown barrx 360 (lot#unknown); unk halo360, unknown halo 360 (lot#unknown).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to the literature study, a single-center retrospective study from a prospectively collected database from 2011 to 2020, 96 patients were treated with four radiofrequency ablation procedure.For the 96 patients analyzed, there were three gastrointestinal bleedings during the follow-up period.There was only one with grade iii gastrointestinal bleeding, which occurred seven days after a treatment session, was directly attributable to radiofrequency ablation treatment which required hospital admission and endoscopic treatment, but no blood transfusion.Two patients reported severe and disabling chest pain (grade i) for up to seven days after radiofrequency ablation.One patient presented with isolated fever after a radiofrequency ablation session, with spontaneous resolution.Fourteen patients presented with post-radiofrequency ablation esophageal strictures (grade iii).Of these, two were diagnosed endoscopically while patients did not suffer from dysphagia.The remaining twelve strictures causing dysphagia were then treated by hydrostatic dilatation, with clinical success in all cases after a median dilatation for patients.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN BARRX
Type of Device
ELECTROSURGICAL, CUTTING & COAGULATION & ACCES
Manufacturer (Section D)
COVIDIEN LP BARRX
covidien gi solutions
sunnyvale CA 94085 4022
Manufacturer (Section G)
COVIDIEN LP BARRX
covidien gi solutions
sunnyvale CA 94085 4022
Manufacturer Contact
justin ellis
8200 coral sea st ne
mounds view, MN 55112
7635265677
MDR Report Key17297951
MDR Text Key318864374
Report Number3004904811-2023-00010
Device Sequence Number1
Product Code GEI
Combination Product (y/n)N
Reporter Country CodeFR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 07/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/11/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNKNOWN BARRX
Device Catalogue NumberUNKNOWN BARRX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/26/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PLEASE SEE NOTE ON H10
Patient Outcome(s) Hospitalization; Required Intervention;
-
-